Mosaic ImmunoEngineering (CPMV) Cash from Investing Activities (2010 - 2023)
Mosaic ImmunoEngineering (CPMV) posted quarterly Cash from Investing Activities of $356000.0 for Q2 2023, up 362.34% quarter-over-quarter from $77000.0 in Q1 2023.
Mosaic ImmunoEngineering (CPMV) Cash from Investing Activities (2010 - 2023) Analysis & Trends
Mosaic ImmunoEngineering's Cash from Investing Activities history runs 14 years deep, the most recent figure standing at $356000.0 for Q2 2023.
- In Q2 2023, Cash from Investing Activities changed N/A year-over-year to $356000.0; the TTM figure through Mar 2024 stood at $356000.0 (down 15.24% YoY), while the FY2023 annual figure was $433000.0, up 26.24% from the prior year.
- Cash from Investing Activities for Q2 2023 stood at $356000.0, up from $77000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $605215.0 in Q3 2020, with the low at -$750000.0 in Q2 2019.
- The 5-year median for Cash from Investing Activities is $250000.0 (2019), against an average of $176233.1.
- The sharpest annual moves came in 2019 and 2020: Cash from Investing Activities slumped 207.14% in 2019, then surged 142.09% in 2020.
- Mosaic ImmunoEngineering's Cash from Investing Activities stood at $500000.0 in 2019, then advanced by 21.04% to $605215.0 in 2020, then tumbled by 95.43% to $27637.0 in 2021, then soared by 1141.09% to $343000.0 in 2022, then increased by 3.79% to $356000.0 in 2023.
- Business Quant data shows CPMV's Cash from Investing Activities at $356000.0 in Q2 2023, $77000.0 in Q1 2023, and $343000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 356,000.00 |
| Jun 30, 2023 | 356,000.00 |
| Mar 31, 2023 | 77,000.00 |
| Mar 31, 2023 | 77,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Mar 31, 2021 | 27,637.00 |
| Mar 31, 2021 | 27,637.00 |
| Aug 31, 2020 | 605,215.00 |
| Aug 31, 2020 | 605,215.00 |
| Nov 30, 2019 | 500,000.00 |
| Nov 30, 2019 | 500,000.00 |
| Aug 31, 2019 | 250,000.00 |
| Aug 31, 2019 | 250,000.00 |
| May 31, 2019 | -750,000.00 |
| May 31, 2019 | -750,000.00 |
| Feb 28, 2019 | 177,246.00 |
| Feb 28, 2019 | 177,246.00 |
| May 31, 2018 | 700,000.00 |
| May 31, 2018 | 700,000.00 |